KR20170125811A - 자스모네이트 유도체 및 그 조성물 - Google Patents
자스모네이트 유도체 및 그 조성물 Download PDFInfo
- Publication number
- KR20170125811A KR20170125811A KR1020177021535A KR20177021535A KR20170125811A KR 20170125811 A KR20170125811 A KR 20170125811A KR 1020177021535 A KR1020177021535 A KR 1020177021535A KR 20177021535 A KR20177021535 A KR 20177021535A KR 20170125811 A KR20170125811 A KR 20170125811A
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- conjugate
- jasmonate
- cancer
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462098704P | 2014-12-31 | 2014-12-31 | |
US62/098,704 | 2014-12-31 | ||
PCT/US2015/068244 WO2016109779A1 (en) | 2014-12-31 | 2015-12-31 | Jasmonate derivatives and compositions thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20170125811A true KR20170125811A (ko) | 2017-11-15 |
Family
ID=56285070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020177021535A KR20170125811A (ko) | 2014-12-31 | 2015-12-31 | 자스모네이트 유도체 및 그 조성물 |
Country Status (11)
Country | Link |
---|---|
US (2) | US10314918B2 (pt) |
EP (1) | EP3240534A4 (pt) |
JP (1) | JP2018502855A (pt) |
KR (1) | KR20170125811A (pt) |
AU (1) | AU2015373915A1 (pt) |
BR (1) | BR112017014229A2 (pt) |
CA (1) | CA2971870A1 (pt) |
IL (1) | IL253212A (pt) |
MX (1) | MX2017008655A (pt) |
WO (1) | WO2016109779A1 (pt) |
ZA (1) | ZA201705100B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190108189A (ko) | 2011-09-16 | 2019-09-23 | 나노케어 테크놀로지스 인코퍼레이티드 | 자스모네이트 화합물의 조성물 및 이의 용도 |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE124422T1 (de) | 1989-04-12 | 1995-07-15 | Procter & Gamble | Festes verbraucherprodukt, welches feinteilige cyclodextrin-komplexe enthält. |
CA2013485C (en) | 1990-03-06 | 1997-04-22 | John Michael Gardlik | Solid consumer product compositions containing small particle cyclodextrin complexes |
US5576016A (en) | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
JP3568325B2 (ja) | 1996-07-12 | 2004-09-22 | 株式会社ノエビア | 抗アンドロゲン剤及び養毛剤並びに毛髪用化粧料 |
JP3596835B2 (ja) | 1996-08-13 | 2004-12-02 | 株式会社ノエビア | 養毛剤 |
CA2293663A1 (en) | 1997-06-09 | 1998-12-17 | The Procter & Gamble Company | Perfumed compositions and methods for reducing body odors and excess moisture |
US6790815B1 (en) | 1998-07-10 | 2004-09-14 | Procter & Gamble Company | Amine reaction compounds comprising one or more active ingredient |
CA2274873A1 (en) | 1999-07-06 | 2001-01-06 | Satinder Gidda | Methods and compositions for modulating flowering |
EP1372739A4 (en) | 2001-03-08 | 2005-10-19 | Targesome Inc | STABILIZED THERAPEUTIC AND IMAGING AGENTS |
US6469061B1 (en) * | 2001-04-04 | 2002-10-22 | Ramot University Authority For Applied Research And Industrial Development Limited | Jasmonate pharmaceutical composition for treatment of cancer |
US20030224024A1 (en) * | 2002-02-04 | 2003-12-04 | Jean-Luc Leveque | Compositions comprising cyclopentane derivatives and their use |
US20040209795A1 (en) | 2003-04-21 | 2004-10-21 | Vlad Florin Joseph | VOC-free microemulsions |
EP1689696A2 (en) | 2003-12-02 | 2006-08-16 | Ramot at Tel-Aviv University Ltd. | Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof |
KR100789343B1 (ko) | 2004-09-07 | 2007-12-28 | 주식회사 엘지생활건강 | 화장용 분체, 그의 제조방법 및 이를 함유하는 메이컵화장품 조성물 |
WO2006056308A2 (de) | 2004-11-25 | 2006-06-01 | Merck Patent Gmbh | Flavonoid-komplexe mit cyclodextrinen |
US7258878B2 (en) | 2004-12-20 | 2007-08-21 | Kimberly-Clark Worldwide, Inc. | Anti-microbial composition and methods of use thereof |
ES2265291B1 (es) | 2005-07-22 | 2008-03-01 | Universidad De Alcala | Nuevos dendrimeros carbosilanos, su preparacion y sus usos. |
WO2007066337A2 (en) | 2005-12-07 | 2007-06-14 | Sepal Pharma Ltd. | Jasmonate derivatives, pharmaceutical compositions and methods of use thereof |
EP2402321A3 (en) | 2005-12-07 | 2012-02-29 | Ramot at Tel Aviv University, Ltd. | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
WO2007103336A2 (en) | 2006-03-06 | 2007-09-13 | The Board Of Trustees Operating | Micro-encapsulation of volatile compounds into cyclodextrins |
WO2007145663A1 (en) | 2006-06-13 | 2007-12-21 | Cargill, Incorporated | Large-particle cyclodextrin inclusion complexes and methods of preparing same |
WO2008007367A1 (en) | 2006-07-10 | 2008-01-17 | Ramot At Tel-Aviv University Ltd. | Combination methods of treating cancer |
BRPI0604024A (pt) | 2006-09-01 | 2008-04-22 | Beyond Lifescience Pesquisa De | alimentos para a prevenção do cáncer e composições farmacêuticas à base do jasmonato |
US20100160623A1 (en) | 2006-12-27 | 2010-06-24 | Cargill, Incorporated | Cyclodextrin inclusion complexes and methods of preparing same |
WO2009019693A2 (en) | 2007-08-07 | 2009-02-12 | Sepal Pharma Sa | Analgesic effect of jasmonate derivatives |
ES2731881T3 (es) | 2007-09-25 | 2019-11-19 | Formulex Pharma Innovations Ltd | Composiciones que comprenden compuestos activos lipófilos y método para su preparación |
GB0721761D0 (en) | 2007-11-06 | 2007-12-19 | Plant Bioscience Ltd | Compositions and methods for synergistic manipulation of plant and insect defences |
WO2009067404A2 (en) | 2007-11-19 | 2009-05-28 | New Biology, Inc. | Methods for improving flowering characteristics using methyl dihydrojasmonate |
KR101199672B1 (ko) | 2008-02-01 | 2012-11-09 | 마리 케이 인코포레이티드 | 방향성 피부활성 성분을 사용하여 피부를 치료하는 방법 |
ES2328002B2 (es) * | 2008-02-29 | 2010-03-29 | Universidad De Alicante | Uso combinado de metil-jasmonato y ciclodextrinas para la produccion de resveratrol. |
BRPI0804172A2 (pt) | 2008-07-15 | 2010-07-06 | Pereira Lopes Jose Emilio Fehr | compostos quìmicos formados a partir de nanoencapsulamentos e complexação de elementos |
AU2010258223B2 (en) | 2009-06-09 | 2014-12-04 | Ramot At Tel-Aviv University Ltd. | Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders |
CN101818100B (zh) | 2010-04-15 | 2012-06-06 | 上海应用技术学院 | 聚氰基丙烯酸丁酯包覆大花茉莉香精胶囊的制备方法 |
ES2610425T3 (es) * | 2010-08-27 | 2017-04-27 | Neonc Technologies Inc. | Composiciones farmacéuticas que comprenden carbamatos de alcohol perilílico |
US20140220132A1 (en) | 2011-02-25 | 2014-08-07 | José E. Fehr Pereira Lopes | Pharmaceutical Formulation Comprising Compounds of the Jasmonate Family |
KR20190108189A (ko) * | 2011-09-16 | 2019-09-23 | 나노케어 테크놀로지스 인코퍼레이티드 | 자스모네이트 화합물의 조성물 및 이의 용도 |
EP2583998B1 (en) | 2011-10-21 | 2018-02-28 | Borealis AG | Polyethylene composition with high rapid crack propagation resistance and pressure resistance |
US9187402B2 (en) * | 2012-06-14 | 2015-11-17 | North Carolina Agricultural And Technical State University | Aspirin derivatives and uses thereof |
EP2872180B1 (en) | 2012-07-10 | 2018-08-08 | baseclick GmbH | Anandamide-modified nucleic acid molecules |
-
2015
- 2015-12-31 JP JP2017535838A patent/JP2018502855A/ja active Pending
- 2015-12-31 MX MX2017008655A patent/MX2017008655A/es unknown
- 2015-12-31 CA CA2971870A patent/CA2971870A1/en not_active Abandoned
- 2015-12-31 EP EP15876338.3A patent/EP3240534A4/en not_active Withdrawn
- 2015-12-31 BR BR112017014229-5A patent/BR112017014229A2/pt not_active Application Discontinuation
- 2015-12-31 WO PCT/US2015/068244 patent/WO2016109779A1/en active Application Filing
- 2015-12-31 AU AU2015373915A patent/AU2015373915A1/en not_active Abandoned
- 2015-12-31 KR KR1020177021535A patent/KR20170125811A/ko unknown
- 2015-12-31 US US15/540,537 patent/US10314918B2/en active Active - Reinstated
-
2017
- 2017-06-28 IL IL253212A patent/IL253212A/en unknown
- 2017-07-26 ZA ZA2017/05100A patent/ZA201705100B/en unknown
-
2019
- 2019-04-24 US US16/393,349 patent/US20200164074A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20170368186A1 (en) | 2017-12-28 |
EP3240534A4 (en) | 2018-12-19 |
EP3240534A1 (en) | 2017-11-08 |
MX2017008655A (es) | 2018-04-10 |
ZA201705100B (en) | 2021-01-27 |
US10314918B2 (en) | 2019-06-11 |
IL253212A (en) | 2018-04-30 |
US20200164074A1 (en) | 2020-05-28 |
CA2971870A1 (en) | 2016-07-07 |
WO2016109779A1 (en) | 2016-07-07 |
AU2015373915A1 (en) | 2017-08-10 |
JP2018502855A (ja) | 2018-02-01 |
BR112017014229A2 (pt) | 2018-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9192644B2 (en) | Bioavailable curcuminoid formulations for treating Alzheimer's disease and other age-related disorders | |
JP2852421B2 (ja) | 燐脂質類に対し、そして少くとも一種類の燐脂質に対して親和性を有する活性物質から成る微結晶、並びにその製造方法及びこの微結晶を含有する薬剤組成物 | |
Koudelka et al. | Liposomes with high encapsulation capacity for paclitaxel: Preparation, characterisation and in vivo anticancer effect | |
AU2015266897A1 (en) | Stable cannabinoid formulations | |
WO2005115470A2 (fr) | COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE β-CARBOLINE, ET LEUR UTILISATION POUR LE TRAITEMENT DES CANCERS | |
HUT74423A (en) | Pharmaceutical basic compositions | |
JP2012162577A (ja) | がん治療のための細胞増殖抑制剤及び電子受容体を含有する医薬製剤 | |
TW201623208A (zh) | 牛樟芝化合物、製備方法及其用途 | |
FR2922107A1 (fr) | Nouvelles compositions a base de taxoides | |
WO2022043407A1 (fr) | Compositions destinées au traitement des troubles neurologiques | |
CN106913882B (zh) | 一种聚乙二醇-藤黄酸脂质体和制备方法及其在治疗恶性肿瘤中的应用 | |
KR20170125811A (ko) | 자스모네이트 유도체 및 그 조성물 | |
BE1022518B1 (fr) | Formulation liposomale immunogene | |
KR20180053406A (ko) | 트리테르페노이드 포함 조성물 | |
BE1024228B1 (fr) | Nouvelles formulations d'adjuvants | |
AU772339B2 (en) | Liposome formulation of 6,9-BIS-((2-aminoethyl)-amino)benzo (G)isoquinoline-5,10-dione dimaleate | |
NZ734000A (en) | Jasmonate derivatives and compositions thereof | |
GB2285804A (en) | Terpinol esters & their use as biotenside solvents for pharmaceuticals and cosmetics | |
EP4312941A1 (en) | Phospholipids as anion chelating agents in pharmaceutical formulations | |
WO2013026989A2 (fr) | Liposome comprenant au moins un derive de cholesterol | |
WO2024084096A1 (en) | Photosensitive diazirine-conjugated phospholipids and uses thereof | |
CN116407503A (zh) | 以五环三萜类化合物为膜材的空白脂质体组合及其制备方法和应用 | |
ITMI951210A1 (it) | Nuovi derivati dell'alfa-tocoferolo e composizioni farmaceutiche che li contengono quali principi attivi |